Seeking Alpha

The Burrill Report » Profile

For 40 years, G. Steven Burrill has been involved in the growth and development of the biotechnology industry. Burrill, the CEO of the merchant bank Burrill & Company and the publisher of The Burrill Report, sees this as a time of both change and opportunity as the rules under which the biotech industry operates are being rewritten.

The Burrill Report (BR) provides actionable market intelligence on the latest global developments and trends in the life sciences industry. Available bi-monthly, subscribers also benefit from monthly market updates and financial and business statistics provided in a special premium area on the Burrill Report Website

Visit The Burrill Report (http://www.burrillreport.com/)

The Burrill Report's Company

Burrill & Co Burrill & Company is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $950 million under management.

Burrill's technical and venture investing competence spans the entire spectrum of life sciences. The expertise of the firm's investment team, strategic partners and Advisory Boards is unparalleled in depth and breadth. In addition, Burrill is a leader in life science strategic partnering, an invaluable practice to build value in portfolio companies and to accelerate their growth and development.

Burrill is also the sponsor and facilitator of several leading annual industry conferences and publishes the seminal annual report on the state of the biotechnology industry. This combination of resources and capabilities has helped Burrill develop a unique and highly effective platform for finding and making outstanding life science investments.

G. Steven Burrill founded Burrill & Company as a logical extension of his 40-year involvement in the growth and prosperity of the biotechnology industry. Mr. Burrill has been an active advisor and catalyst in some of the industry's most notable companies and transactions. Mr. Burrill's close involvement and respected position within the industry has positioned the firm as a prominent deal-maker and facilitator of industry partnerships and alliances, all of which fosters a robust deal flow. Further contributing to this deal flow are: the scientific and business networks of its investment team; the Advisory Boards; the strategic and financial network of its limited partners; and the close relationships developed with numerous life science companies and management as a result of Burrill's visibility, reputation, and the firm's partnering and alliance work.

Having created a strong organization of respected professionals from the life science industry worldwide, Burrill & Company stands in the mainstream of life science deal flow and its visibility in the industry is unrivaled.

To download our media kit, click here.
Visit http://www.burrillandco.com »

The Burrill Report's Blog

The Burrill Report The Burrill Report (BR) provides actionable market intelligence on the latest global developments and trends in the life sciences industry. Available bi-monthly, subscribers also benefit from monthly market updates and financial and business statistics provided in a special premium area on the Burrill Report Website
Visit http://www.burrillreport.com/ »

The Burrill Report's Book

Biotech 2009 Life Sciences: Navigating the Sea Change Burrill Media is the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a wide range of bio-intelligence reports. Annual conferences include The Biotech Meeting, The Indiana Life Sciences Forum, The Burrill Personalized Medicine Meeting, The Aging Meeting and The Stem Cell Meeting. Burrill Media publications include the annual State of the Industry, The Personalized Medicine Report, The Stem Cell Report, and periodic newsletters covering Canada, China, Europe, India, Japan and Partnering/M&A. Burrill also publishes The Burrill Report, a bimonthly magazine.
Visit http://www.burrillandco.com/Biotech2009.html »
Articles by The Burrill Report »
Snapshot
  • Venture Capitalist
  • Trading frequency: Weekly
Interests:
  • Mutual Funds